ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Biosimilars – How it started"
Episode Synopsis
Biosimilars have been around in the U.S. since Zarxio was approved by the FDA in 2015, and the vernacular can get confusing. Dr. Shannon Smallwood, Senior Pharmacy Executive and host Gretchen Brummel address the basics of biosimilars for the masses.
Guest speaker:
Shannon Smallwood, PharmD, BCPS
Senior Pharmacy Executive
Vizient
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:40-01:25] Biosimilar definition
[01:26-01:52] Comparisons to generic medications
[01:53-02:42] Difference in biobetters and biologics
[02:43-05:18] History of biosimilars
[05:19 -07:05] Payer responsive model
[07:06-08:16] What frontline staff should know about biosimilars
[08:17-09:18] What Shannon is watching for next year
Links | Resources:
NCCN Pharmacy Directors Forum Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Guest speaker:
Shannon Smallwood, PharmD, BCPS
Senior Pharmacy Executive
Vizient
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:40-01:25] Biosimilar definition
[01:26-01:52] Comparisons to generic medications
[01:53-02:42] Difference in biobetters and biologics
[02:43-05:18] History of biosimilars
[05:19 -07:05] Payer responsive model
[07:06-08:16] What frontline staff should know about biosimilars
[08:17-09:18] What Shannon is watching for next year
Links | Resources:
NCCN Pharmacy Directors Forum Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
More episodes of the podcast VerifiedRx
The GOAT of GPO’s
30/12/2025
Challenges with AI in Pharmacy
28/10/2025
Tapping into NTAP
30/09/2025
GLN Changes You Can’t Ignore
16/09/2025
Inside the New Joint Commission Manual
26/08/2025
In God we trust